Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Beyond CLL Progression: Unveiling Th17 and Th2 T Cell Subsets As Predictors of Pembrolizumab Response in Richter's Transformation

Prajish Iyer, Lu Yang, Sutapa Sinha, Miles Del Busso, Zhi-Zhang Yang, Hyojin Kim, Charla Secreto, Yucai Wang, Neil E. Kay, Stephen M Ansell, Wei Ding, Lili Wang

Blood (2023) 142 (Supplement 1): 1888.

https://doi.org/10.1182/blood-2023-181004

Published: 2023

Journal Articles

Mutations in Driver Genes and Changes in Clonal Dynamics Are Associated with Shorter Time to Treatment in MBL Cases

Santiago Barrio, Juhi Ojha, PhD, Charla Secreto, SR Research Technologist, Kari G. Chaffee, MS, klaus Martin Kortum, Sachin Pathangey, Susan L. Slager, PhD, Rafael Fonseca, MD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Esteban Braggio, PhD

Blood (2015) 126 (23): 5264.

https://doi.org/10.1182/blood.V126.23.5264.5264

Published: 2015

Journal Articles

Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia

Juhi Ojha, Jackline Ayres, Charla Secreto, Renee Tschumper, Kari Rabe, Daniel Van Dyke, Susan Slager, Tait Shanafelt, Rafael Fonseca, Neil E. Kay, Esteban Braggio

Blood (2015) 125 (3): 492–498.

https://doi.org/10.1182/blood-2014-06-580563

Published: 2015

Includes: Supplemental data

Journal Articles

Axl Regulates Fibroblast Growth Factor Receptor Signaling in B-Cell Chronic Lymphocytic Leukemia: Dual Targeting in CLL Therapy

Sutapa Sinha, PhD, Justin Boysen, Charla Secreto, Steven L. Warner, PhD, Neil E. Kay, MD, Asish K Ghosh, PhD

Blood (2014) 124 (21): 831.

https://doi.org/10.1182/blood.V124.21.831.831

Published: 2014

Journal Articles

Targeted Inhibition of Axl Primes Chronic Lymphocytic Leukemia B-Cells for Apoptosis: Synergistic/Additive Effects in Combination with Bruton Tyrosine Kinase Inhibitors

Sutapa Sinha, PhD, Justin Boysen, Michael Nelson, Charla Secreto, Steven L. Warner, PhD, David J. Bearss, PhD, Connie Lesnick, M.Sc, Tait D. Shanafelt, MD, Neil E. Kay, MD, Asish K Ghosh, PhD

Blood (2014) 124 (21): 1946.

https://doi.org/10.1182/blood.V124.21.1946.1946

Published: 2014

Journal Articles

Novel Phenotypic and Genetic Analysis of T-Cell Prolymphocytic Leukemia (T-PLL)

Henan Zhang, Esteban Braggio, PhD, Jaime Davila, PhD, Andrew L. Feldman, MD, Timothy G. Call, MD, Thomas E. Witzig, MD, Yi Lin, MDPhD, Charla Secreto, Mrinal M. Patnaik, MBBS, James R Cerhan, MD PhD, Sameer A. Parikh, MD, Saurabh Baheti, Wei Ding, MD PhD

Blood (2014) 124 (21): 1682.

https://doi.org/10.1182/blood.V124.21.1682.1682

Published: 2014

Journal Articles

CLL Mesenchymal Stromal Cells Have Decreased Replicative Potential and Senescent Phenotype: Clinical and Biologic Implications

Wei Ding, MD PhD, Charla Secreto, Xiaosheng Wu, PhD, Esteban Braggio, PhD, Yuji Zhang, PhD, Stephanie A. Smoley, Tait D. Shanafelt, MD, Jaime Davila, PhD, Timothy G Call, MD, Daniel L. Van Dyke, PhD, Diane F. Jelinek, Neil E. Kay, MD

Blood (2014) 124 (21): 3282.

https://doi.org/10.1182/blood.V124.21.3282.3282

Published: 2014

Journal Articles

The AKT Inhibitor MK2206 In Combination With Rituximab and Bendamustine Is Tolerable and Active In Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results From a Phase 1 Study (NCCTG N1087 Alliance)

Wei Ding, MD, PhD, Tait D Shanafelt, MD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Betsy R. LaPlant, Timothy G. Call, MD, Curtis A Hanson, MD, Charles Erlichman, MD, Thomas M. Habermann, MD, Craig Reeder, MD, Daniel Nikcevich, Deborah Bowen, CNP, Michael J. Conte, PA-C, Justin Boysen, Charla Secreto, Connie Lesnick, M.Sc, Renee C. Tschumper, Diane F. Jelinek, PhD, Neil E. Kay, MD

Blood (2013) 122 (21): 2882.

https://doi.org/10.1182/blood.V122.21.2882.2882

Published: 2013

Journal Articles

Genomic Landscape and Clonal Heterogeneity Underlying Progression and Relapse In Chronic Lymphocytic Leukemia (CLL)

Juhi Ojha, PhD, Jackline Ayres-Silva, Charla Secreto, Scott Van Wier, Susan L Slager, PhD, Rafael Fonseca, M.D., Tait D Shanafelt, MD, Neil E. Kay, MD, Esteban Braggio, Ph.D.

Blood (2013) 122 (21): 2855.

https://doi.org/10.1182/blood.V122.21.2855.2855

Published: 2013

Journal Articles

Allosteric Akt Inhibitor MK2206 Synergizes with Bendamustine in Promoting the Apoptosis of Chronic Lymphocytic Leukemia Cells and Selectively Targets B-Cell Receptor Mediated Cytokine Production

Wei Ding, MD, PhD, Tait D. Shanafelt, MD, Connie Lesnick, M.Sc, Traci Sassoon, Charla Secreto, Charles Erlichman, MD, Jose Leis, MD, PhD, Timothy G. Call, MD, Deborah Bowen, CNP, Shaji K. Kumar, MD, Neil E. Kay, MD

Blood (2012) 120 (21): 3928.

https://doi.org/10.1182/blood.V120.21.3928.3928

Published: 2012

Journal Articles

Axl Receptor Tyrosine Kinase Signaling Pathway and the p53 Tumor Suppressor Protein Exist In A Novel Regulatory Loop In B-Cell Chronic Lymphocytic Leukemia Cells

Asish K Ghosh, PhD, Justin Boysen, Tammy Price-troska, Charla Secreto, Clive S. Zent, MD, Neil Kay, MD

Blood (2011) 118 (21): 799.

https://doi.org/10.1182/blood.V118.21.799.799

Published: 2011

Journal Articles

Mesenchymal Stromal Cells Derived From Chronic Lymphocytic Leukemic Patients Express Different Genes and Produce Different Cytokines Compared to MSC Derived From Normal Subjects,

Wei Ding, MD, PhD, Traci Sassoon, Esteban Braggio, PhD, Charla Secreto, Neil Kay, MD

Blood (2011) 118 (21): 3872.

https://doi.org/10.1182/blood.V118.21.3872.3872

Published: 2011

Journal Articles

TRIS (DIBENZYLIDENEACETONE) Dipalladium a Small-Molecule Palladium Complex Is Effective in the Induction of Apoptosis for B-Chronic Lymphocytic Leukemia B-Cells

Neil Kay, MD, Traci Sassoon, Charla Secreto, Asish K Ghosh, PhD, Jack L Arbiser

Blood (2011) 118 (21): 2851.

https://doi.org/10.1182/blood.V118.21.2851.2851

Published: 2011

Journal Articles

The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy

Asish K. Ghosh, Charla Secreto, Justin Boysen, Traci Sassoon, Tait D. Shanafelt, Debabrata Mukhopadhyay, Neil E. Kay

Blood (2011) 117 (6): 1928–1937.

https://doi.org/10.1182/blood-2010-09-305649

Published: 2011

Includes: Supplemental data

Journal Articles

A Novel Receptor Tyrosine Kinase Axl is Constitutively Active in B-Cell Chronic Lymphocytic Leukemia and Acts as a Docking Site of Non-Receptor Kinases: Implications for Therapy

Asish K Ghosh, PhD, Charla Secreto, Justin Boysen, Traci Sassoon, Sacha Holland, Tait Shanafelt, MD, Debabrata Mukhopadhyay, Neil E. Kay

Blood (2010) 116 (21): 54.

https://doi.org/10.1182/blood.V116.21.54.54

Published: 2010

Journal Articles

Role of Platelet-Derived Growth Factor On Vascular Endothelial Growth Factor Synthesis by Mesenchymal Stem Cells in Chronic Lymphocytic Leukemia: Implications for Clinical Progression.

Wei Ding, MD, PhD, Traci Knox, Susan Schwager, Charla Secreto, Asish K Ghosh, PhD, Wenting Wu, Neil E. Kay, MD

Blood (2009) 114 (22): 804.

https://doi.org/10.1182/blood.V114.22.804.804

Published: 2009

Journal Articles

Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells

Asish K. Ghosh, Tait D. Shanafelt, Amelia Cimmino, Cristian Taccioli, Stefano Volinia, Chang-gong Liu, George A. Calin, Carlo M. Croce, Denise A. Chan, Amato J. Giaccia, Charla Secreto, Linda E. Wellik, Yean K. Lee, Debabrata Mukhopadhyay, Neil E. Kay

Blood (2009) 113 (22): 5568–5574.

https://doi.org/10.1182/blood-2008-10-185686

Published: 2009

Journal Articles

Predictors of Clinical Outcome to Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by Campath for Relapsed/Refractory CLL – A Study of the Eastern Cooperative Oncology Group, E2903.

Neil E. Kay, MD, Haesook T Kim, PhD., Sanford Kempin, MD, Charla Secreto, Traci Knox, Renee Tschumper, Diane F Jelinek, Stephanie Smoley, Daniel VanDyke, Joel Saltzman, MD, Steven T. Rosen, MD, Brad Kahl, MD, Martin S. Tallman, MD

Blood (2008) 112 (11): 1057.

https://doi.org/10.1182/blood.V112.11.1057.1057

Published: 2008

Journal Articles

Mcl-1 as a Possible Predictor of Progression-Free Survival in Previously Untreated Chronic Lymphocytic Leukemia Patients Treated with Pentostatin, Cyclophosphamide and Rituximab.

Farrukh Awan, MD, MS, Neil E. Kay, Melanie Davis, Wenting Wu, Nelson Leung, Diane F. Jelinek, Renee Tschumper, Charla Secreto, Thomas S. Lin, Michael R Grever, MD, Tait Shanafelt, MD, Clive S. Zent, Timothy G. Call, Nyla A. Heerema, PhD, Gerard Lozanski, John C. Byrd, MD, David Lucas, PhD

Blood (2008) 112 (11): 2105.

https://doi.org/10.1182/blood.V112.11.2105.2105

Published: 2008

Journal Articles

Dietary Products Induce Apoptosis in CLL B Cells and Reveal Potential as a Therapeutic Combination That Can Overcome Stromal Cell Mediated Protection.

Asish K. Ghosh, PhD, Tait D. Shanafelt, MD, Charla Secreto, Neil E. Kay, MD

Blood (2007) 110 (11): 3130.

https://doi.org/10.1182/blood.V110.11.3130.3130

Published: 2007

NARROW

Beyond CLL Progression: Unveiling Th17 and Th2 T Cell Subsets As Predictors of Pembrolizumab Response in Richter's Transformation

Mutations in Driver Genes and Changes in Clonal Dynamics Are Associated with Shorter Time to Treatment in MBL Cases

Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia

Axl Regulates Fibroblast Growth Factor Receptor Signaling in B-Cell Chronic Lymphocytic Leukemia: Dual Targeting in CLL Therapy

Targeted Inhibition of Axl Primes Chronic Lymphocytic Leukemia B-Cells for Apoptosis: Synergistic/Additive Effects in Combination with Bruton Tyrosine Kinase Inhibitors

Novel Phenotypic and Genetic Analysis of T-Cell Prolymphocytic Leukemia (T-PLL)

CLL Mesenchymal Stromal Cells Have Decreased Replicative Potential and Senescent Phenotype: Clinical and Biologic Implications

The AKT Inhibitor MK2206 In Combination With Rituximab and Bendamustine Is Tolerable and Active In Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results From a Phase 1 Study (NCCTG N1087 Alliance)

Genomic Landscape and Clonal Heterogeneity Underlying Progression and Relapse In Chronic Lymphocytic Leukemia (CLL)

Allosteric Akt Inhibitor MK2206 Synergizes with Bendamustine in Promoting the Apoptosis of Chronic Lymphocytic Leukemia Cells and Selectively Targets B-Cell Receptor Mediated Cytokine Production

Axl Receptor Tyrosine Kinase Signaling Pathway and the p53 Tumor Suppressor Protein Exist In A Novel Regulatory Loop In B-Cell Chronic Lymphocytic Leukemia Cells

Mesenchymal Stromal Cells Derived From Chronic Lymphocytic Leukemic Patients Express Different Genes and Produce Different Cytokines Compared to MSC Derived From Normal Subjects,

TRIS (DIBENZYLIDENEACETONE) Dipalladium a Small-Molecule Palladium Complex Is Effective in the Induction of Apoptosis for B-Chronic Lymphocytic Leukemia B-Cells

The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy

A Novel Receptor Tyrosine Kinase Axl is Constitutively Active in B-Cell Chronic Lymphocytic Leukemia and Acts as a Docking Site of Non-Receptor Kinases: Implications for Therapy

Role of Platelet-Derived Growth Factor On Vascular Endothelial Growth Factor Synthesis by Mesenchymal Stem Cells in Chronic Lymphocytic Leukemia: Implications for Clinical Progression.

Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells

Predictors of Clinical Outcome to Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by Campath for Relapsed/Refractory CLL – A Study of the Eastern Cooperative Oncology Group, E2903.

Mcl-1 as a Possible Predictor of Progression-Free Survival in Previously Untreated Chronic Lymphocytic Leukemia Patients Treated with Pentostatin, Cyclophosphamide and Rituximab.

Dietary Products Induce Apoptosis in CLL B Cells and Reveal Potential as a Therapeutic Combination That Can Overcome Stromal Cell Mediated Protection.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only